We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+11.91%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$619M
AUM Growth
+$153M
Cap. Flow
+$108M
Cap. Flow %
17.48%
Top 10 Hldgs %
23.79%
Holding
1,975
New
1,076
Increased
246
Reduced
281
Closed
278

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$2.9M
2
NUE icon
Nucor
NUE
+$2.82M
3
LKM
Link Motion Inc.
LKM
+$2.62M
4
GLD icon
SPDR Gold Trust
GLD
+$2.26M
5
GDI
GARDNER DENVER,INC
GDI
+$2.25M

Sector Composition

Rank Sector Weight
1 Energy 11.58%
2 Consumer Discretionary 7.63%
3 Industrials 6.66%
4 Technology 6.27%
5 Real Estate 6.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TZA icon
1201
Direxion Daily Small Cap Bear 3x ETF
TZA
$210M
$23K ﹤0.01%
+1
New +$40.9K
PXD
1202
DELISTED
Pioneer Natural Resource Co.
PXD
$23K ﹤0.01%
+120
New +$20.4K
WPRT
1203
PUT
Westport Fuel Systems
WPRT
$35.7M
$22K ﹤0.01%
90
DXYN
1204
DELISTED
Dixie Group Inc
DXYN
$22K ﹤0.01%
+2,000
New +$20.2K
TRQ
1205
DELISTED
Turquoise Hill Resources Ltd
TRQ
$22K ﹤0.01%
650
-1,948
-75% -$76.7K
NAFC
1206
DELISTED
NASH FINCH CO
NAFC
$22K ﹤0.01%
+839
New +$21K
TECUB
1207
DELISTED
TECUMSEH PRODUCTS CO CL-B
TECUB
$22K ﹤0.01%
+2,500
New +$22K
SVVC
1208
DELISTED
Firsthand Technology Value Fund, Inc. Common Stock
SVVC
$21K ﹤0.01%
+874
New +$19.4K
ARO
1209
DELISTED
Aeropostale Inc
ARO
$20K ﹤0.01%
+2,153
New +$25.6K
BIO icon
1210
Bio-Rad Laboratories Class A
BIO
$9.42B
$19K ﹤0.01%
+160
New +$18.9K
RY icon
1211
Royal Bank of Canada
RY
$293B
$19K ﹤0.01%
+300
New +$18.6K
SIGA icon
1212
CALL
SIGA Technologies
SIGA
$219M
$19K ﹤0.01%
+5,000
New +$17.1K
TROX icon
1213
Tronox
TROX
$1.04B
$19K ﹤0.01%
763
-2,177
-74% -$48.3K
CASC
1214
DELISTED
Cascadian Therapeutics, Inc.
CASC
$19K ﹤0.01%
+1,515
New +$15.9K
RKT
1215
DELISTED
ROCK-TENN COMPANY CL-A
RKT
$19K ﹤0.01%
384
-4,466
-92% -$249K
PVFC
1216
DELISTED
PVF CAPITAL CORP
PVFC
$19K ﹤0.01%
4,496
EDE
1217
DELISTED
Empire District Electric
EDE
$19K ﹤0.01%
+900
New +$20.2K
ACHV icon
1218
Achieve Life Sciences
ACHV
$683M
$18K ﹤0.01%
1
-1
-50% -$20.7K
DEL
1219
DELISTED
Deltic Timber
DEL
$18K ﹤0.01%
+280
New +$17.6K
NBIX icon
1220
Neurocrine Biosciences
NBIX
$16.6B
$17K ﹤0.01%
+1,500
New +$20.6K
PBA icon
1221
Pembina Pipeline
PBA
$27.6B
$17K ﹤0.01%
+500
New +$15.7K
SANW
1222
DELISTED
S&W Seed Co
SANW
$17K ﹤0.01%
+105
New +$15.8K
INFI
1223
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$17K ﹤0.01%
1,000
-9,048
-90% -$173K
B
1224
Barrick Mining
B
$73.2B
$15K ﹤0.01%
800
-2,400
-75% -$42.3K
LSTA icon
1225
Lisata Therapeutics
LSTA
$9.65M
$15K ﹤0.01%
+12
New +$13.3K

Similar funds

Prelude Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Prelude Capital Management held 1,975 positions worth $619M, up 33% from $466M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Prelude Capital Management deployed $108M of net new capital in Q3 2013, opening 1,076 new positions and adding to 246 existing holdings. Its largest new stake was NetApp: 82,300 shares worth $3.51M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Apple, an estimated $2.9M trimmed.

  • Prelude Capital Management's largest Q3 2013 buy was NetApp: 82,300 shares worth $3.51M.
  • Prelude Capital Management added most to Herc Holdings in Q3 2013, an estimated $2.74M increase.
  • Prelude Capital Management's biggest Q3 2013 reduction was Apple, cutting an estimated $2.9M.
  • Prelude Capital Management fully exited Nucor in Q3 2013, selling an estimated $2.82M.
  • Prelude Capital Management's ten largest holdings make up 24% of its $619M portfolio in Q3 2013.
  • Prelude Capital Management opened 1,076 new positions and closed 278 in Q3 2013.
  • Prelude Capital Management's portfolio value rose 33% quarter-over-quarter to $619M.

Based on Prelude Capital Management's 13F filing for Q3 2013, filed 14 Nov 2013.